H.I.G. Capital: Strategic Investments in Healthcare and Beyond

H.I.G. Capital, a prominent global investment firm, has been making significant strides in the healthcare sector and adjacent industries. With $65 billion in assets under management, the company is strategically expanding its portfolio to capitalize on growing market opportunities.

Recently, H.I.G. Capital acquired SkinCure Oncology, a leader in non-invasive cancer treatments. This acquisition allows the firm to tap into the burgeoning market of image-guided superficial radiation therapy, a promising alternative for nonmelanoma skin cancer. By partnering with over 500 physicians across the U.S., SkinCure Oncology has successfully treated more than 100,000 patients, solidifying its position in the healthcare landscape.

In addition to its healthcare ventures, H.I.G. Capital broadened its focus with the sale of BIOVECTRA to Agilent Technologies for a substantial $925 million. BIOVECTRA, a contract development and manufacturing organization, thrived under H.I.G.’s stewardship, expanding its facilities and shifting towards commercial products. This sale underscores H.I.G.’s knack for nurturing growth and driving sales in companies it acquires.

Furthermore, H.I.G. Capital’s acquisition of Naturalia Tantum S.p.A. highlights its interest in sustainable consumer goods. This Italian firm excels in organic beauty and personal care products, tapping into the escalating demand for natural and environmentally friendly solutions.

A notable move outside traditional healthcare was H.I.G.’s acquisition of Action Elevator, a company providing maintenance and repair services, including to healthcare facilities. This acquisition further solidifies H.I.G. Capital’s presence in sectors that support healthcare infrastructure.

With these diverse investments, H.I.G. Capital continues to position itself as a formidable player, leveraging its vast resources to foster growth in healthcare and related industries.

H.I.G. Capital, a prominent global investment firm, has been making significant strides in the healthcare sector and adjacent industries. With $65 billion in assets under management, the company is strategically expanding its portfolio to capitalize on growing market opportunities. Recently, H.I.G. Capital acquired SkinCure Oncology, a leader in non-invasive cancer treatments. This acquisition allows the…